China’s Hua Medicine mulls Hong Kong IPO as diabetes drug enters crucial clinical trial phase Jan 12, 2018 Life Science
Resverlogix Receives FDA Protocol Acceptance for the Ongoing Phase 3 BETonMACE Trial Jan 11, 2018 Life Science
BeiGene And Mirati Therapeutics Announce Exclusive License Agreement For Sitravatinib In The Asia Pacific Region Jan 9, 2018 Life Science
BeiGene and Boehringer Ingelheim Announce Commercial Supply Agreement for Anti-PD-1 Antibody Tislelizumab Jan 9, 2018 Life Science
Genostics Invests $13.5 Million in UK’s Oncimmune for China Rights to Lung Cancer Test Jan 4, 2018 Life Science
